Advertisement

Topics

Appointments: IFPMA, Myokardia, ABPI, Mission Therapeutics, F2G, Arquer Diagnostics and Innovative Medicines Canada

23:00 EST 12 Dec 2016 | SCRIP

This week's roundup includes top level updates from AstraZeneca and executive appointments by Myokardia, Asceneuron and Arquer Diagnostics.

      

Related Stories

 

Original Article: Appointments: IFPMA, Myokardia, ABPI, Mission Therapeutics, F2G, Arquer Diagnostics and Innovative Medicines Canada

NEXT ARTICLE

More From BioPortfolio on "Appointments: IFPMA, Myokardia, ABPI, Mission Therapeutics, F2G, Arquer Diagnostics and Innovative Medicines Canada"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...